Asymptomatic target-organs damage as additional determinant of global cardiovascular risk in arterial hypertension

March 7, 2019

An analytical review about prognostic significance of asymptomatic target-organs damage diagnostics in arterial hypertension in context of more detailed assessment of cardiovascular risk is presented in the article. The main instrumental and functional tests for the diagnostics of the subclinical stages of the target-organs damage in arterial hypertension are presented and their prognostic significance for the global cardiovascular events is determined.

Published: 07.03.2019


  • Clase C.M., Barzilay J., Gao P. et al. (2017) Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes. Kidney Int., 91(3): 683–690.
  • Perrone-Filardi P., Coca A., Galderisi M. et al. (2017) Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH). Eur. Heart J. Cardiovasc. Imaging, 18(9): 945–960.
  • Sairenchi T., Iso H., Yamagishi K. et al. (2011) Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study. Circulation, 124(23): 2502–2511.
  • Tsoi K.K., Chan J.Y., Hirai H.W. et al. (2015) Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern. Med., 175: 1450–1458.
  • Volpe M., Battistoni A., Tocci G. et al. (2012) Cardiovascular risk assessment beyond systemic coronary risk estimation: a role for organ damage markers. J. Hypertens., 30: 1056–1064.
  • Williams B., Mancia G., Spiering W. et al.; ESC Scientific Document Group (2018) 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J., 39(33): 3021–3104.